当前位置:首页 - 行情中心 - 京新药业(002020) - 财务分析 - 现金流量表

京新药业

(002020)

  

流通市值:81.81亿  总市值:97.30亿
流通股本:7.24亿   总股本:8.61亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,964,840,434.98949,825,279.233,786,397,989.292,846,292,493.75
  收到的税费返还23,427,975.1611,189,012.8246,620,740.7838,807,179.72
  收到其他与经营活动有关的现金46,168,125.7321,780,413.13113,274,579.7105,589,670.51
  经营活动现金流入小计2,034,436,535.87982,794,705.183,946,293,309.772,990,689,343.98
  购买商品、接受劳务支付的现金593,599,784.54319,050,733.691,432,363,922.981,020,986,605.26
  支付给职工以及为职工支付的现金350,805,223.67167,685,869.19628,410,872.32483,059,750.78
  支付的各项税费252,386,224.68148,980,607.24353,287,492.08299,252,402.1
  支付其他与经营活动有关的现金360,733,261.79165,221,029.09750,883,949.55571,906,772.47
  经营活动现金流出小计1,557,524,494.68800,938,239.213,164,946,236.932,375,205,530.61
  经营活动产生的现金流量净额476,912,041.19181,856,465.97781,347,072.84615,483,813.37
二、投资活动产生的现金流量:
  收回投资收到的现金2,616,318,253.381,634,260,381.922,709,900,1002,013,000,000
  取得投资收益收到的现金39,432,702.1125,639,901.0927,159,592.4525,444,241.94
  处置固定资产、无形资产和其他长期资产收回的现金净额644,259256,2333,887,457.6396,616.9
  投资活动现金流入小计2,656,395,214.491,660,156,516.012,740,947,150.052,038,840,858.84
  购建固定资产、无形资产和其他长期资产支付的现金126,741,359.7488,213,905.44202,850,821.93158,475,046.19
  投资支付的现金2,680,632,669.281,867,633,569.282,170,990,3521,365,900,000
  投资活动现金流出小计2,807,374,029.021,955,847,474.722,373,841,173.931,524,375,046.19
  投资活动产生的现金流量净额-150,978,814.53-295,690,958.71367,105,976.12514,465,812.65
三、筹资活动产生的现金流量:
  取得借款收到的现金169,250,074.99-566,978,516.64372,767,886.11
  收到其他与筹资活动有关的现金89,193,943.4389,042,500368,162.81368,162.81
  筹资活动现金流入小计258,444,018.4289,042,500567,346,679.45373,136,048.92
  偿还债务支付的现金285,000,00070,000,000567,000,000442,000,000
  分配股利、利润或偿付利息支付的现金290,930,276.99-288,540,870.41288,540,870.41
  其中:子公司支付给少数股东的股利、利润3,621,841.24-3,687,124.663,687,124.66
  支付其他与筹资活动有关的现金27,331,413.316,744,654.88627,554,733.13623,973,550.36
  筹资活动现金流出小计603,261,690.2986,744,654.881,483,095,603.541,354,514,420.77
  筹资活动产生的现金流量净额-344,817,671.872,297,845.12-915,748,924.09-981,378,371.85
四、汇率变动对现金及现金等价物的影响-16,558,377.64-10,431,386.1-7,217,125.84-2,087,506.29
五、现金及现金等价物净增加额-35,442,822.85-121,968,033.72225,486,999.03146,483,747.88
  加:期初现金及现金等价物余额512,631,931.73512,675,332.7287,144,932.7287,144,932.7
  期末现金及现金等价物余额477,189,108.88390,707,298.98512,631,931.73433,628,680.58
补充资料:
  净利润355,950,434.85-766,667,967.92-
  资产减值准备45,333,057.39-53,295,486.44-
  固定资产和投资性房地产折旧126,068,611.46-252,057,462.72-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧126,068,611.46-252,057,462.72-
  无形资产摊销11,231,284.8-21,257,731.27-
  长期待摊费用摊销7,142,895.89-15,380,447.38-
  处置固定资产、无形资产和其他长期资产的损失-6,123,990.05-574,497.63-
  固定资产报废损失5,067,275.98-50,777.86-
  公允价值变动损失16,701,364.37--9,470,848.64-
  财务费用7,737,092.76--33,345,222.17-
  投资损失-12,784,347.93--17,108,923.46-
  递延所得税-2,480,549.69-8,951,161.55-
  其中:递延所得税资产减少3,634,596.43-4,326,434.38-
    递延所得税负债增加-6,115,146.12-4,624,727.17-
  存货的减少-55,350,266.7--5,227,251.15-
  经营性应收项目的减少99,757,787.45--26,571,327.94-
  经营性应付项目的增加-128,356,975.84--258,731,692.52-
  其他---437,868.71-
  现金的期末余额477,189,108.88-512,631,931.73-
  减:现金的期初余额512,631,931.73-287,144,932.7-
  现金及现金等价物的净增加额-35,442,822.85-225,486,999.03-
公告日期2026-08-272026-04-242026-04-242025-10-30
审计意见(境内)标准无保留意见
TOP↑